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The Hippo tumor suppressor pathway regulates intestinal
stem cell regeneration
Phillip Karpowicz1,*, Jessica Perez1 and Norbert Perrimon1,2,*

SUMMARY
Identification of the signaling pathways that control the proliferation of stem cells (SCs), and whether they act in a cell or noncell autonomous manner, is key to our understanding of tissue homeostasis and cancer. In the adult Drosophila midgut, the Jun
N-Terminal Kinase (JNK) pathway is activated in damaged enterocyte cells (ECs) following injury. This leads to the production of
Upd cytokines from ECs, which in turn activate the Janus kinase (JAK)/Signal transducer and activator of transcription (STAT)
pathway in Intestinal SCs (ISCs), stimulating their proliferation. In addition, the Hippo pathway has been recently implicated in
the regulation of Upd production from the ECs. Here, we show that the Hippo pathway target, Yorkie (Yki), also plays a crucial
and cell-autonomous role in ISCs. Activation of Yki in ISCs is sufficient to increase ISC proliferation, a process involving Yki target
genes that promote division, survival and the Upd cytokines. We further show that prior to injury, Yki activity is constitutively
repressed by the upstream Hippo pathway members Fat and Dachsous (Ds). These findings demonstrate a cell-autonomous role
for the Hippo pathway in SCs, and have implications for understanding the role of this pathway in tumorigenesis and cancer stem
cells.

INTRODUCTION
SCs underlie the turnover of differentiated cells in many adult
tissues (Blanpain and Fuchs, 2009; Reya et al., 2001). In the
absence of damage, the baseline level at which SCs replace
differentiated cells can be thought of as ‘normal homeostasis’.
After an acute injury when many cells are simultaneously lost,
these are replaced expediently by an increase in SC or transitamplifying progenitor cell division (Blanpain and Fuchs, 2009; Ito
et al., 2005; Jiang et al., 2009). This accelerated cell production,
which can be thought of as ‘acute regeneration’, allows the
damaged tissue to return to its original size and to its normal
homeostatic state. The transition from normal homeostasis to acute
regeneration occurs quickly and often during the lifetime of an
animal, as tissues can be damaged by exposure to pathogens,
chemical and mechanical injuries, and disease conditions. Yet, the
cell biology and molecular mechanisms that mediate this switch are
poorly understood.
Understanding how SCs stop dividing during tissue regeneration
is of fundamental importance, not only to regenerative medicine,
but also in understanding the evasion of growth control during
oncogenesis (Hanahan and Weinberg, 2000). In recent years, the
Hippo signaling pathway has emerged as an evolutionarily
conserved pathway intimately connected to the regulation of organ
growth and cancer (Saucedo and Edgar, 2007). Genetic studies in
Drosophila have identified a number of its signaling components
and provided a framework of the structure of this pathway.
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Activation of the Serine/Threonine kinase Hippo (Hpo) leads to the
suppression of the transcriptional co-activator Yorkie (Yki) (Dong
et al., 2007; Huang et al., 2005). Overexpression of Yki or
mutations in any one of the Hippo pathway members, such as the
Serine/Threonine kinase Warts (Wts), lead to cellular proliferation
coupled with resistance to cell death (Hamaratoglu et al., 2006;
Saucedo and Edgar, 2007; Willecke et al., 2006; Wu et al., 2003b).
Hence, the current model is that Hippo signaling acts to prevent
Yki from causing tissue hyperplasia. The most upstream
components of the pathway, Fat and Ds, are atypical cadherins that
share limited similarities with classic Type 1 cadherins (Bennett
and Harvey, 2006; Halbleib and Nelson, 2006; Willecke et al.,
2006). Fat is thought to be a receptor for Ds, and one model of
Hippo signaling pathway is that their binding initiates signaling in
the cells expressing Fat (Matakatsu and Blair, 2004; Rogulja et al.,
2008; Willecke et al., 2008). This model provides insight into how
a cell might sense its surrounding neighbors and simultaneously
regulate its growth and division.
Insensitivity to growth control itself is a defining feature of
cancer (Hanahan and Weinberg, 2000), thus placing the Hippo
pathway as an important candidate in tumorigenesis. Indeed, a
number of recent studies support this notion. The human orthologs
of Drosophila Yki, YAP1/2 are oncogenes (Zender et al., 2006),
the overexpression of which has been linked to hyperplasia in the
liver and small intestine of mice (Camargo et al., 2007; Dong et al.,
2007). Mammalian orthologs of the Hippo pathway have conserved
roles and their disruption also induces growth (Zeng and Hong,
2008). For example, mice mutant for Lats, the ortholog of
Drosophila Wts, develop ovarian tumors and soft-tissue sarcomas
(St John et al., 1999) and mutations in Mst1/2, the ortholog of
Drosophila Hpo, lead to liver tumors (Zhou et al., 2009). These
studies underscore the importance of this pathway in controlling
growth in cancer, but it is unclear how Hippo growth control occurs
constitutively in adult tissues and what its role might be therein.
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MATERIALS AND METHODS
Transgenic and mutant lines

Drosophila stocks were as follows:
w1118
hsFlp; act>CD2>Gal4, UAS-nlsGFP/CyO
MST1096-Gal4/CyO
esg-Gal4, UAS-GFP, Tub-Gal80TS
Tub-Gal80TS/FM7; esg-Gal4/CyO
Tub-Gal80TS/FM7; myo1A-Gal4, UAS-GFP/CyO
yw; UAS-srcGFP; pros-Gal4
hsFlp, Tub-Gal4, UAS-GFP/FM7; Tub-Gal80, FRT40A/CyO
hsFlp, Tub-Gal4, UAS-GFP/FM7; Tub-Gal80, FRT82B/TM6 B
hsFlp, Tub-Gal4, UAS-GFP/FM7; FRT42D, Tub-Gal80/CyO
w; arm-LacZ, FRT40A/CyO

w; FRT42D arm-LacZ
w; FRT42D ykiB5/CyO
w; FRT42D hpo42-47/CyO
IF/CyO; wtsX1, FRT82B/TM6B
w; exe1, FRT40A/CyO
UAS-hpoKD(II)
UAS-hpo (II)
UAS-yki/TM3 Sb
yw; UAS-ykiS168A::GFP (II)
ds-LacZ; cn1/CyO
w; ex-LacZ
DIAP1-LacZ (2BC2 on X)
DIAP1-LacZ/TM6B
CycE-LacZ (III)
bantam GFP sensor/CyO
Upd-LacZ
w; 10xSTAT-GFP (II)
UAS-Upd/CyO
UAS-hopTUML/CyO
UAS-p35
The following RNAi stocks were obtained from the TRiP (Harvard
Medical School, Boston, MA, USA):
SH00018.0 (white #1); JF01545 (white #2); JF03245 (fat); JF02842
(dachsous); JF03120 (expanded); JF02841 (merlin); SH00079.N (hippo
#1); JF02740 (hippo #2); SH00083.N (warts #1); JF02741 (warts #2);
SH00081.N (yorkie #1); JF01666 (yorkie #2); SH00045.N (Stat92E) and
JF01268 (hopscotch).
Information on these lines can be found at http://www.flyrnai.org/TRiPHOME.html.
Temperature-controlled expression

Crosses were carried out at 18°C using the temperature-sensitive Esg (esgGal4, UAS-GFP, Tub-Gal80TS) or NP1 drivers (Tub-Gal80TS/FM7; myo1AGal4, UAS-GFP/CyO). Offspring were maintained at 18°C to 2-3 days
post-eclosion, then shifted to 29°C to suppress Gal80. Flies were
transferred onto fresh media every 1-2 days. Guts were examined at the
timepoints indicated in the figures. RNAi against the white gene was
carried out to control for RNAi effects in this system, these were identical
to w1118 controls (data not shown).
Mosaic analysis

Crosses and progeny were maintained at 25°C to the indicated times, and
transferred onto fresh media every 1-2 days. For flip-out clones (Basler and
Struhl, 1994) (hsFlp; act>CD2>Gal4, UAS-nlsGFP/CyO), a single 10-,
30- or 45-minute 37°C heat shock was applied to 2- to 3-day-old flies.
MARCM clones (hsFlp, Tub-Gal4, UAS-nlsGFP/+; arm-LacZ,
FRT40A/Gal80TS FRT40A and hsFlp, Tub-Gal4, UAS-nlsGFP/+; wtsX1,
FRT82B/Gal80TS, FRT82B and hsFlp, Tub-Gal4, UAS-nlsGFP/+; exe1,
FRT40A/Gal80TS, FRT40A), were exposed to either a single 45-minute or
two 1-hour 37°C heat shocks at 2-3 days following eclosion. In both flip
out and MARCM clones, the minimal heat shock time was applied for
clonal analysis. One or two MARCM clones per five guts were noted in
non-heat shocked flies, indicating some leakiness in the MARCM system.
This does not affect our analysis because >10 clones were scored per
midgut, with ~10 midguts scored per condition. A region of leaky GFP
expression was noted in the anterior region of the midgut using the flip out
system (hsFlp; act>CD2>Gal4, UAS-nlsGFP/CyO); thus, this region was
omitted from these analyses. Both MARCM and flip out clones were
scored as clusters of two or more adjacent cells.
Feeding

Flies were maintained on 5% w/v sucrose + H2O for the timepoints
indicated. Flies were fed 5% w/v DSS (MP Biomedicals) dissolved in
sucrose (Amcheslavsky et al., 2009), or Pseudomonas aeruginosa bacteria
(Apidianakis et al., 2009). Pseudomonas was grown in LB media with 100
g/l Rifampicin (Sigma) overnight at 32°C, 50 ml aliquots of these
bacterial cultures were spun down and one pellet was reconstituted in 500
l sucrose. For the chase, flies were exposed to DSS as above, then
maintained on normal media at 18°C up to the timepoint indicated.
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Furthermore, whereas Type 1 cadherins have been found to play
important roles in SC biology (Song et al., 2002), the roles of
atypical cadherin components of the Hippo pathway in SCs have
not yet been investigated in detail.
To explore the role of the Hippo pathway in SCs specifically, we
decided to examine its role in the Drosophila midgut epithelium,
which contains a self-renewing population of ISCs that maintain
homeostasis in the adult (Micchelli and Perrimon, 2006; Ohlstein
and Spradling, 2006). The lineage of ISCs is simple, as these cells
divide to produce enteroblasts (Eb) that differentiate directly into
an enterocyte (EC) or enteroendocrine cell (ee) without further
division (Fig. 1A). Two signaling pathways, Wnt (Lee et al., 2009;
Lin et al., 2008) and Notch (Ohlstein and Spradling, 2007), ensure
the division of ISCs and differentiation of ISC progeny,
respectively. Two studies on acute regeneration have so far
identified ECs as sensors of damage, and ISCs as responders to
cues originating from ECs (Jiang et al., 2009; Staley and Irvine,
2010). For example, in the event of injury, Jun N-Terminal Kinase
(JNK) signaling is activated in dying ECs, which are thought to
subsequently secrete Unpaired (Upd) cytokines – Upd/Os, Upd2
and Upd3 – to activate JAK/STAT signaling in ISCs (Jiang et al.,
2009). In response, ISCs increase their rate of division and the
regenerative response of ISCs ceases once their progeny replace the
cells lost due to injury. In addition, Staley and Irvine (Staley and
Irvine, 2010) recently reported that injury-induced JNK activity
results in the activation of Yki in ECs (Staley and Irvine, 2010),
placing Hippo signaling between JNK and JAK/STAT signaling in
the EC response to acute injury. Importantly, this study failed to
demonstrate a role for the Hippo pathway in the ISCs themselves.
We sought to examine a role for Hippo signaling in ISCs, and, in
contrast to Staley and Irvine (Staley and Irvine, 2010), we
demonstrate a cell autonomous role for the Hippo pathway in these
cells. We show that ISC proliferation is constitutively controlled by
the Hippo pathway, in part through the upstream components Fat and
Ds, and that this control is perturbed by damage. Using both ISCspecific overexpression and loss of function experiments, we
demonstrate that Yki activation is crucial in ISCs during acute
regeneration. Specifically, we show that yki mutant clones are unable
to participate in acute regeneration, and find an important role for the
Hippo pathway in promoting ISC survival. Furthermore, we
demonstrate that the ability of Yki to promote proliferation is also
mediated through the autocrine activation of the JAK/ STAT pathway.
Thus, similar to its role in ECs, Yki regulates the expression of the
Upd cytokines in ISCs, activating JAK/STAT signaling in ISCs
themselves. These findings reveal a redundancy in both autocrine and
paracrine JAK/STAT activity during regeneration and, altogether,
demonstrate a novel function for the Hippo pathway in ISCs that
occurs in parallel to the indirect Hippo pathway activity in ECs.
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Dissection and staining

Female guts were dissected in 1⫻PBS (Gibco) and fixed in either: (1) 4%
paraformaldehyde (Electron Microscopy Sciences) diluted with 1⫻PBS or
(2) 5% paraformaldehyde diluted in 100 mM sodium phosphate buffer
(Sigma) for 40 minutes. Samples were washed three times with PBS, then
blocked for 30 minutes in 1⫻PBS, 1% BSA (Sigma) and 0.2% Triton X100 (Sigma). Samples were stained for primary antibodies overnight at 4°C
using the following antibodies: mouse anti-Armadillo, mouse anti-Delta,
mouse anti-Prospero (Developmental Studies Hybridoma Bank), rat antiYki (a gift from Helen McNeill, Mount Sinai Hospital, Toronto, Canada),
rat anti-Fat (a gift from Michael Simon, Stanford University School of
Medicine, Stanford, CA, USA), rat anti-Ds (a gift from Michael Simon),
rabbit anti-Yki (a gift from Ken Irvine, Rutgers University, Piscataway, NJ,
USA) and rabbit anti--galactosidase (Cappel). Samples were washed three
times in PBS, and stained at 4°C for 1.5 hours with secondary antibodies
as follows: donkey anti-mouse Alexa 555, donkey anti-mouse Alexa 594,
donkey anti-mouse Alexa 647, goat anti-rat Alexa 555, donkey anti-rabbit
Alexa 594, goat anti-rabbit Alexa 647 (Molecular Probes) and goat anti-rat
HRP (Millipore). Following secondary staining with HRP-conjugated
antibody, Fat protein signal was amplified using the Tyramide TSA Kit
(Perkin Elmer, #NEL700A) as per the manufacturer’s instructions. TUNEL
labeling (Roche, #12156792910 In situ Cell Death Kit, TMR Red) was
performed according to the manufacturer’s instructions. All samples were
counterstained with DAPI (Molecular Probes) for 10 minutes, washed three
times with PBS, and mounted using Vectashield (Vector).
RT-qPCR

Twelve midguts from each genotype were dissected and collected on ice
(n3 biological replicates). RNA was isolated using the RNEasy Mini Kit
(Qiagen) and cDNA was transcribed using the iScript cDNA Synthesis Kit
(Biorad). qPCR was then performed using iQ SYBR Green Supermix on
a CFX96 Real-Time System/C1000 Thermal Cycler (Biorad). All samples
were treated according to the manufacturer’s instructions, gene expression
was normalized to the control transcript Rp49, then normalized relative to
the w1118 control. qPRC primers used were: Rp49-F, ATCGGTTACGGATCGAACAA; Rp49-R, GACAATCTCCTTGCGCTTCT; Upd-F,
TCAGCTCAGCATCCCAATCAG; Upd-R, ATAGTCGATCCAGTTGCTGTTCCG; Upd2-F, TGCTATCGCTGAGGCTCTCG; Upd2-R,
GACTCTTCTCCGGCAAATCAGA; Upd3-F, AAATTGAATGCCAGCAGTACG; Upd3-R, CCTTGCTGTGCGTTTCGTTC; Ex-F, GCACCGCACCATTGTTCATC; Ex-R, CAACTGATGGCTGCAAACCG.
Microscopy

Fluorescent microscopy was performed on a Zeiss Axioskop 2motplus
upright, confocal images were obtained using the Leica TCS SP2 AOBS
system.
Data analysis

Images were processed in Photoshop CS2. Statistics (t-test or ANOVA as
appropriate) were carried out using Graphpad Prism 5.0. The frequency of
Esg(+) cell per field of view (FOV) was determined as the ratio of Esg(+)
cells/total number of DAPI(+) nuclei (including ISCs, Ebs, ECs and ee
cells) taken in one region of the posterior midgut using a 40⫻ objective.
Using this method, ~300-400 cells were scored per midgut, and at least six
midguts were analyzed per genotype.

RESULTS
To address whether the Hippo pathway is involved in ISC growth
control following regeneration, we first examined whether the
target of the Hippo pathway is expressed by ISCs. The Drosophila
midgut ISC and Eb cells express the transcription factor Escargot
(Esg) (Micchelli and Perrimon, 2006). We found that Esg(+) cells
in the posterior midgut were enriched for Yki, but that its
localization was predominantly cytoplasmic (Fig. 1B). This
cytoplasmic localization of Yki suggests that it is inactivated in
these cells, as Yki phosphorylation and exclusion from the nucleus
is regulated by Hippo signaling (Dong et al., 2007). Only following
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translocation into the nucleus, can Yki activate transcription factors
involved in growth during development (Dong et al., 2007; Oh and
Irvine, 2008; Saucedo and Edgar, 2007). The cytoplasmic
localization of Yki in ISCs suggests that removal of Yki should not
lead to any obvious ISC phenotypes, which we tested by
knockdown of Yki by RNAi in the midgut using the temperaturecontrolled Esg-Gal4 system. No obvious undergrowth phenotype
was noticed when Yki RNAi is expressed in ISC/Eb cells (Fig.
1D). This result is probably not due to the RNAi reagent that we
used, as RNAi against Yki in the Drosophila wing, where Yki is
required for normal organ growth, produces a severe undergrowth
phenotype (Fig. 1C) and reduces Yki protein levels (see Fig. S1A
in the supplementary material).
Next, we tested whether overexpression of either wild-type Yki,
or the constitutively active YkiS168A, in ISCs could affect their
proliferative abilities. Strikingly, although removal of Yki showed
no phenotype in the midgut, overexpression of Yki in ISCs
increased division, as judged by an increase in mitotic
phosphorylated-Histone3 positive nuclei, and also increased
ISC/Eb frequency, as shown by an increase in esg>GFP signal (Fig.
1D,E). Our results contrast with the recent report of Staley and
Irvine (Staley and Irvine, 2010), who failed to detect a phenotype
in ISC following overexpression of Yki in ISCs. This may be due
to a difference in the strength of the expressed Yki in these cells,
as we used a wild-type UAS-yki transgene (Huang et al., 2005) and
the UAS-ykiS168A:GFP (Oh and Irvine, 2008), both of which are
random transgene insertions. The UAS-ykiS168A:V5 used in by
Staley and Irvine is a targeted insertion (attP2 at 68A) (Oh and
Irvine, 2009). Indeed, division was induced only 18 hours after Yki
overexpression in ISC/Ebs using the esg-Gal4 driver, suggesting
that Yki plays a cell-autonomous role when it is activated in these
cells (see Fig. S1C in the supplementary material).
To further analyze the effect of Yki expression, we compared
the size of clones of cells overexpressing Yki with wild type.
When examined at 14 days after induction, wild-type clones
typically contain fewer than 10 cells (see Fig. 2F), most of which
are ECs, distinguished by their large polyploid nuclear size
(Micchelli and Perrimon, 2006; Ohlstein and Spradling, 2006);
only one or two are ISCs, distinguished by the expression of the
ISC marker Delta (Dl) (Ohlstein and Spradling, 2007) (Fig. 1F).
Yki-overexpressing clones were larger than in wild type and
sometimes contained more than two Dl(+) cells, suggesting either
an expansion of the ISC number or stress, which has been shown
to prevent the differentiation of Dl(+) Eb cells (Biteau et al., 2008)
(Fig. 1F; see Fig. S2 in the supplementary material). However, the
presence of large Dl(–), polyploid EC nuclei and staining for the
ee marker Prospero (Ohlstein and Spradling, 2007) (Pros) (see Fig.
S2A in the supplementary material) suggests that differentiation
of Ebs is not impaired following Yki overexpression. Loss-offunction yki clones were also examined and, consistent with our
RNAi depletion (Fig. 1D), no difference was noted between these
and their wild-type counterparts under normal conditions (Fig. 1F,
Fig. 2E,F). Clonal analysis was then applied using yki RNAi to
further confirm these findings (see Fig. S2 in the supplementary
material).
As Yki cytoplasmic retention is caused by Hippo signaling, we
carried out RNAi experiments against components of the Hippo
pathway to determine whether these repress Yki in ISCs.
Knockdown of Hpo, Wts, Mer, Expanded (Ex) and Fat in ISCs
produced an increase in both ISC/Eb frequency and ISC division
in the midgut (Fig. 2A,B). For example, by 11 days, knockdown of
Hpo produced a strong phenotype that closely resembled the
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overexpression of Yki in these cells (Fig. 2A). Some variability in
the frequency of Esg(+) cells was observed at different time points,
most likely reflecting variability in the level of knockdowns
associated with RNAi (see Fig. S4A,B in the supplementary
material). To corroborate the finding that Hippo signaling
deactivation in ISCs leads to overproliferation, the overexpression
of a dominant-negative kinase dead Hpo transgene (Wu et al.,
2003a) was found to elicit a similar phenotype as RNAi (Fig. 2B).
To further investigate the effect of removal of Hpo, we compared
the size of hpo mutant clones (Fig. 2D,F) and clones expressing
Hpo RNAi (see Fig. S2 in the supplementary material) with wild
type. The loss of Hpo also increased the proportion of large clones
(Fig. 2F), and slightly increased the proportion of Dl(+) cells per
clone (see Fig. S3C in the supplementary material). An expansion
in clone number was observed. Whereas the frequency of at least
two-cell wild-type clones is constant over time, the frequency of
hpo mutant and RNAi-depleted clones increases over the same
period (Fig. 2E; see Fig. S2 in the supplementary material). These
data suggest either an expansion in ISC number and their dispersal
from the initial clones into the midgut epithelium, or the expansion
of the surrounding tissue which separates ISC clones. It has been
suggested that ISCs may mobilize in the gut epithelium (Ohlstein
and Spradling, 2006), and our results support this notion. Similar

clones were obtained using yki overexpression and the Hippo
pathway mutant alleles wtsX1 and exe1 (see Figs S2, S3 in the
supplementary material). We stained clones for Pros and found that
ee production was not affected by the loss of hpo (see Fig. S3C in
the supplementary material). Similarly ECs are present in hpo
clones (see Figs S2, S3 in the supplementary material), indicating
that differentiation is not impaired in the absence of Hpo pathway
activity. Quantification of Dl(+) and Pros(+) cell number using the
Esg-Gal4 driver, further confirmed the ability of Ebs to
differentiate with either Yki overexpression or Hippo pathway
knockdown (see Fig. S4C in the supplementary material).
An important question is whether the proliferation observed in
response to Yki activity or Hippo signaling disruption was due to
the division of ISCs or whether Ebs, which normally do not divide,
could be induced to proliferate. We noted little overlap in Esg(+)
and markers of differentiation, Pros (not shown) and Pdm1 (see
Fig. S4D in the supplementary material). Staining for the ISC
marker Dl and phosphorylated-Histone3 revealed that nearly all of
the mitotic events occurred in Dl(+) cells (Fig. 3A) suggesting that
it is the ISC division and not the division of transit amplifying
progenitors that is regulated by Hippo signaling. However, we
cannot exclude the possibility that Ebs dedifferentiate into ISCs
under the control of the Hippo pathway.
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Fig. 1. Yorkie induces ISC/Eb overproliferation
in the gut epithelium. (A)The ISC lineage.
(B)Esg(+) ISC/Eb cells in the wild-type posterior
midgut epithelium stained with anti-Yki antibody.
(C)Shown are: (i) wild type (w1118/+; MST1096Gal4/+) versus (ii) Yorkie RNAi (MST1096-Gal4/+; yki
RNAi-1/+) adult wings. (D)Confocal micrographs of
wild type (first panel is esg>GFP: w1118/+; esg-Gal4,
UAS-GFP, Tub-Gal80TS/+), RNAi against yki (middle
panel is esg>yki RNAi-1: esg-Gal4, UAS-GFP, TubGal80TS/+; yki RNAi-1/+) and overexpression of yki
(left panel is esg>yki: esg-Gal4, UAS-GFP, TubGal80TS/+; UAS-yki/+). The same hairpin that
reduces wing size in C has no effect on ISC
proliferation, whereas yki overexpression causes
overproliferation. (E)Quantification of total mitoses
in the entire midgut (left), and the frequency of
Esg(+) cells in one field of view (FOV) in the
posterior region of the midgut (right). All constructs
were expressed in ISC/Eb cells. Both Yki and
mutated Yki (YkiS168A) accelerated cell division,
whereas RNAi constructs against yki produced no
apparent changes when compared with wild type
(Ctrl). Error bars indicate s.e.m. (P<0.05).
(F)Confocal images showing Yki-overexpressing
clones (shown on right, yki is hsFlp/+; UAS-GFP,
act>CD2>Gal4/+; UAS-yki/+) and wild-type clones
(left, w1118 is hsFlp/+; UAS-GFP, act>CD2>Gal4/+).
Clones mutant for yki (ykiB5 is hsFlp, Tub-Gal4, UASnlsGFP/+; FRT42D, Tub-Gal80TS/FRT42D ykiB5) are no
different from wild-type (arm-LacZ is hsFlp, TubGal4, UAS-nlsGFP/+; FRT42D, Tub-Gal80TS/FRT42D
arm-LacZ).
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Interestingly, knockdown of the Hippo pathway ligand Ds in
ISCs did not increase ISCs/Eb frequency or ISC division (Fig. 2B).
Ds is thought to act as the ligand of Fat through which cell-cell
contact signaling is achieved (Matakatsu and Blair, 2004; Rogulja
et al., 2008; Willecke et al., 2008), and the depletion of Fat in ISCs
leads to ISC overproliferation. Thus, the nests of ISCs/Ebs, which
are surrounded by their EC progeny, might be signaling through the
Fat/Ds cadherins. We tested the effect of removing Ds in ECs using
the temperature-sensitive NP1 Myo1A-Gal4 driver that is
expressed in EC cells (Jiang et al., 2009) (see Fig. S5B in the
supplementary material). Strikingly, knockdown of Ds produced
overproliferation if carried out in ECs (Fig. 2C) but did not seem
to affect the proportions of ISC or ee cells present (see Fig. S4C in
the supplementary material). To provide further support to our
functional analyses, we examined the expression of Hippo pathway
components in the midgut epithelium. The receptor of the Hippo
signaling pathway, Fat, was found to be expressed in the Esg(+)
cells (Fig. 3B), including Dl(+) ISCs (see Fig. S5A in the
supplementary material). Its ligand, Ds, was also present in the
midgut epithelial cells, in particular along the borders of EC cells
(Fig. 3C), as well as along the borders where diploid Esg(+) cells
attached to their EC neighbors. Ds staining was not uniform
throughout the epithelium, suggesting that either the expression of
the ligand is dynamically regulated, or that gut epithelial cells are

heterogenous for the expression Ds. To determine which cells
express the Ds ligand, a ds-LacZ reporter was used that carries a
lacZ insertion in the ds gene. Staining for -galactosidase revealed
that ds expression is present in EC cells but that not all ECs
expressed ds strongly (Fig. 3D). We found that ee cells also express
ds, whereas Esg(+) ISC/Eb cells did not show high ds expression
(Fig. 3E). Altogether, our analysis suggests that ISCs and Eb cells
express Fat, while their differentiated progeny express Ds, most
likely to inhibit tissue expansion. The observation that Ds
expression appears dynamic suggests that EC and ee cells might
only express Ds transiently, e.g. depending on their maturity during
differentiation. Alternatively, it is possible that only some subtypes
of EC and ee cells express Ds.
Our data demonstrate that the Hippo signaling pathway limits
the proliferation of ISCs but does not affect the differentiation of
Eb progeny. The complete inhibition of Yki in ISCs raises the issue
of what role this transcriptional co-activator plays in this system.
The regeneration of damaged tissue provides a context where ISCs
must divide quickly to replace lost cells in the midgut epithelium.
Therefore, we tested whether the loss of Yki activity would have
consequences on the proliferation of ISCs in a gut regeneration
model. Midguts in which Yki was knocked down by RNAi were
exposed to dextran sodium sulfate (DSS) (Fig. 4A) and
Pseudomonas bacteria, both of which have previously been shown
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Fig. 2. Perturbation of Hippo signaling causes
hyperplasia in the gut epithelium. (A)RNAi
against hpo leads to overproliferation (bottom
panel is esg>hpo RNAi-1: esg-Gal4, UAS-GFP, TubGal80TS/+; hpo RNAi-1/+) when compared with
wild type (top panel is esg>GFP: w1118/+; esg-Gal4,
UAS-GFP, Tub-Gal80TS/+). (B)Quantification of
Esg(+) cell frequency (top) and mitoses (bottom). ds
RNAi shows no difference compared with wild type
(Ctrl), whereas every other Hippo pathway member
tested shows overproliferation when expressed in
ISC/Eb cells. Error bars indicate s.e.m. (P<0.05).
(C)When ds is knocked down in ECs (TubGal80TS/+; myo1A-Gal4, UAS-GFP/+; ds RNAi/+), it
causes strong overproliferation. Error bars indicate
s.e.m. (P<0.05). (D)Mosaic analysis shows that hpo
mutation (hpo42-47 is hsFlp, Tub-Gal4, UASnlsGFP/+; FRT42D, Tub-Gal80TS/FRT42D hpo42-47)
phenocopies yki overexpression (compare with Fig.
1F). (E)Quantification of clonal frequency reveals an
expansion in clone number in hpo mutant clones,
but not in yki mutant clones, which are similar to
wild type (arm-LacZ). Genotypes are same as above,
frequencies are shown as percentage normalized to
the 4-day timepoint when each gut contained 5-15
clones in total (n10-12 guts examined at each
timepoint). Error bars indicate s.e.m. (P<0.05).
(F) Histograms show that large clones are more
frequent among hpo mutant clones than in wild
type (arm-LacZ) or yki mutants. Brackets show total
number of clones analyzed at this timepoint (14
days after clone induction).
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to induce tissue injury (Amcheslavsky et al., 2009; Apidianakis et
al., 2009; Jiang et al., 2009). Yki depletion strongly suppressed the
DSS-induced division of ISCs (Fig. 4A,B) whereas Pseudomonas
showed a lesser effect (Fig. 4B). Under both DSS and
Pseudomonas damage conditions, the division of ISCs and
frequency of ISCs/Ebs in the posterior midgut was decreased (Fig.
4B,C), confirming that the damage response is reduced when Yki
is knocked down. We re-examined yki mutant clones under injury
conditions (Fig. 4D,4E) and found that the size of the clones was
significantly reduced from their former levels, in the absence of
damage, where they were equivalent to controls (Fig. 1F, Fig. 2F).
Yki mutant clones were also less frequent than wild types during
DSS damage: whereas wild-type clones increased in frequency to
7.8±1.7 times their original numbers, yki clones increased to only
2.8±0.6 times theirs. The expansion of clones during damage again
suggests the dispersal of ISCs during tissue regeneration. The
presence of dividing yki mutant clones itself suggests that Yki is
not needed for the survival of all ISCs during damage, but their
small size and reduced frequency suggests that Yki is needed for
either the survival of their differentiated progeny or for the
proliferation of ISCs following injury. Cell death was examined
using TUNEL labeling, but no increases in apoptosis were
observed in ykiB5 clones (see Fig. S7 in the supplementary
material), suggesting that Yki primarily functions to increase
division. The survival requirement was further tested by the
simultaneous depletion of yki and overexpression of the cell death
inhibitor p35 (Fig. 4B). P35 was able to partially rescue the loss of
dividing cells but not the decrease in Esg(+) under DSS injury

conditions. Thus, we find some evidence that supports a role for
Yki in preventing the cell death of ISCs during damage. Because
under normal homeostasis, Yki overexpression induces ISC
division (Fig. 1, Fig. 3A), it seems likely that Yki functions in ISCs
to promote both proliferation and survival.
The activation of Yki and its targets (which are normally
suppressed by Hippo signaling) were further investigated.
Staining of endogenous Yki in damaged wild-type midguts
revealed that the nuclear signal of Yki increases in Esg(+)
ISCs/Ebs, similar to what is observed when Hpo is knocked
down in these cells (see Fig. S6 in the supplementary material).
The targets of Yki include the cell cycle regulator CyclinE
(CycE), the apoptosis inhibitor DIAP1 and the microRNA
bantam. Flies carrying reporters of these target genes were
examined when injured by DSS and Pseudomonas bacteria (see
Figs S8, S9 in the supplementary material). CycE, DIAP1 and
bantam targets were elevated under both conditions of injury,
although an increase in DIAP1 was also noted in EC cells.
Altogether, these data demonstrate that, following injury, Yki
functions to increase the regenerative capacity of ISCs. We also
examined the expression of Ex, a component of the Hippo
pathway itself regulated by the pathway (Hamaratoglu et al.,
2006; Saucedo and Edgar, 2007) (see Figs S8, S9 in the
supplementary material). Interestingly, ex reporter expression
was transiently increased following injury but then returned to
baseline levels when environmental insult was removed (Fig.
4F). This suggests that after acute regeneration is complete, Yki
is deactivated to slow down accelerated ISC division.
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Fig. 3. Hippo signaling occurs in different cell
types within the midgut epithelium.
(A)Confocal images show wild type (left panel is
esg>GFP: w1118/+; esg-Gal4, UAS-GFP, TubGal80TS/+), overexpression of yki (center panel is
esg>yki: esg-Gal4, UAS-GFP, Tub-Gal80TS/+; UASyki/+) and RNAi against hpo (right panel is esg>hpo
RNAi-1: esg-Gal4, UAS-GFP, Tub-Gal80TS/+; hpo
RNAi-1/+) stained for Dl (green) and phosphorylated
Histone 3 (red). Nearly all mitotic cells are also Dl(+),
as revealed by quantification of percentages
(number of phospho-H3 cells counted are in
brackets). (B)Fat staining is located in the basal
region of wild-type posterior gut epithelium. Top
panels show confocal sections through the
epithelial wall, with an ISC labeled for Esg (green)
located basally. The outside of the gut is just below
the ISC. A crescent of Fat protein, coincident with
Armadillo (Arm) which marks the cell cortex, is
located between the ISC and its neighboring EC
cells. Lower panels show confocal sections taken
through the basal region of the epithelium, where
ISC/Eb cells are located. Fat staining is present
around the cortex of Esg(+) cells. (C)Confocal
images show that the Ds protein, also coincident
with Arm, is located at the edges of wild-type ECs –
in some cases where the ECs appose Esg(+) cells.
(D)Confocal images of a Tub-Gal80TS/ds-LacZ;
myo1A-Gal4, UAS-GFP/+ posterior midgut. ds-LacZ
is expressed in the EC cells which are GFP-labeled
using the NP1 Gal4 driver. (E)Confocal images of a
ds-LacZ/+; esg-Gal4, UAS-GFP, Tub-Gal80TS/+
midgut. Strong ds-LacZ expression is also present in
Pros(+) ee cells.
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The constitutive expression of Yki in ISCs reveals that these
cells are primed to divide very rapidly. The baseline division of
these cells is once per day (Ohlstein and Spradling, 2006) – even
though their maximal cell cycle rate is much higher. This is evident
under conditions of damage, where tissue loss induces much
greater ISC output (Jiang et al., 2009). It has been shown that the
response to damage involves the release of Upd cytokines,
resulting in the activation of the JAK/STAT pathway (Jiang et al.,
2009). To examine the relationship between JAK/STAT and Hippo
signaling, we depleted both Hpo and the Janus kinase Hopscotch
(Hop), or its target Stat92E, simultaneously in the ISCs.
Concomitant Hpo and Yki knockdown (Fig. 5A,B) inhibited
overproliferation induced by Hpo knockdown alone, consistent
with Hpo acting through Yki. Similarly, Hop or Stat92E
knockdown also suppressed Hpo depletion-dependant
overproliferation, indicating that the JAK/STAT pathway acts either
downstream or in parallel to Hpo (Fig. 5A,B). The same effects

were observed when Yki was overexpressed and either Stat92E or
Hop were depleted (see Fig. S10B in the supplementary material).
Stat92E suppression of ISC division was somewhat less, but this
was due to the infrequent presence of localized hyperplasias (see
Fig. S10A in the supplementary material), which have been
previously reported to occur in a subset of Stat92E mutant clones
(Beebe et al., 2010).
We next activated JAK/STAT signaling by overexpressing
Upd/Os, or a constitutively active form of Hop and concomitantly
depleted Yki (Fig. 5C). In contrast to the requirement of
JAK/STAT activity for Yki-accelerated division, JAK/STAT
activation resulted in overproliferation independent of Yki.
Simultaneous knockdown of Yki and Hop, or Yki and Stat92E did
not differ greatly from depletion of Yki alone (Fig. 5C). These
interactions between the Hippo and JAK/STAT pathways were also
recapitulated in the context of injury (see Fig. S11 in the
supplementary material). To further test whether these pathways
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Fig. 4. Yki accelerates ISC division
during regeneration. (A)The Ykidepleted midgut (bottom panel is esg>yki
RNAi-1: esg-Gal4, UAS-GFP, TubGal80TS/+; yki RNAi-1/+) contains fewer
Esg(+) cells in response to DSS-induced
damage, compared with the wild-type
gut (top panel is esg>GFP: w1118/+; esgGal4, UAS-GFP, Tub-Gal80TS/+).
(B)Quantification of mitoses shows that
DSS (top) and Pseudomonas (bottom)
exposure reduces the regenerative
response of ISCs expressing yki RNAi
constructs. Error bars indicate s.e.m.
(P<0.05). (C)The frequency of Esg(+) cells
in the posterior midgut is also reduced,
when flies are fed either DSS or
Pseudomonas, and Yki is concomitantly
depleted. Error bars indicate s.e.m.
(P<0.05). (D)Confocal images show a
reduction in the size of yki mutant clones
(ykiB5) when compared with wild type
(arm-LacZ) when the midgut is injured,
although both contain ISCs marked by Dl
(arrows). (E)After injury, yki mutant
clones are smaller than wild type (armLacZ). However, under baseline
conditions, these are similar in size to wild
type. Brackets show total number of
clones analyzed at this timepoint (14 days
after clone induction), error bars indicate
s.e.m. (P<0.05). (F)Confocal images
showing the esg>Gal4/ex-LacZ reporter
line (esg-Gal4, UAS-GFP, Tub-Gal80TS/exLacZ) under normal conditions and injury
conditions. Samples were prepared
identically and images were taken using
the same parameters.
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Fig. 5. JAK/STAT is integrated with
Hippo signaling. (A)When hpo is depleted
(top panel is esg>hpo RNAi-1: esg-Gal4,
UAS-GFP, Tub-Gal80TS/+; hpo RNAi-1/+), cell
division is increased. Knockdown of Yki
(middle panel is esg>hpo RNAi-1, yki RNAi1: esg-Gal4, UAS-GFP, Tub-Gal80TS/+; hpo
RNAi-1/yki RNAi-1) and Stat92E (bottom
panel is esg>hpo RNAi-1, stat92E RNAi:
esg-Gal4, UAS-GFP, Tub-Gal80TS/+; hpo
RNAi-1/stat92E RNAi) suppress this
overproliferation. (B)Quantification of
Esg(+) cell frequency (top) and mitosis
(bottom). The depletion of yki, hop and
stat92E suppress the overproliferation
observed due to hpo depletion alone. Error
bars indicate s.e.m. (P<0.05).
(C)Quantification of Esg(+) cell frequency
and mitosis, shows that when yki is
depleted, JAK/STAT activation still results in
increased proliferation. If both yki and hop,
or yki and stat92E are depleted, no
significant differences are observed from yki
depletion alone. Error bars indicate s.e.m.
(P<0.05). (D)Graphs show quantification of
mitosis and Esg(+) cell frequency as above,
genotypes examined are the same for both
graph y-axes. The values for esg>yki and
esg>hpo RNAi-1 are reproduced from Fig.
1E and Fig. 2B in order to compare the
increase. Error bars indicate s.e.m. (P<0.05).

targets of Yki in ISC/Eb cells. We further examined whether Yki
is required for JAK/STAT activity in these cells when the midgut
is undergoing damage. Neither JAK/STAT activity (Fig. 6A) nor
Upd/Os production (Fig. 6C) was abolished when yki was depleted
in ISCs/Ebs, indicating that Yki facilitates Upd/Os production but
is not required to activate JAK/STAT activity during regeneration.
Moreover, residual STAT activity, which functions independently
of Yki, may account for the incomplete suppression of regeneration
when yki is lost (Fig. 4).
DISCUSSION
We have analyzed the role of the Hippo pathway in the adult
midgut and find several lines of evidence supporting a direct role
for the Hippo pathway in ISCs. First, we show that Yki protein is
enriched in ISCs (Fig. 1B), and that depletion of the Hippo
pathway components that repress Yki in ISCs, leads to ISC
overproliferation (Fig. 2, Fig. 3A). Second, we find that the Yki
transcriptional targets CycE, Ex, and DIAP1 are upregulated in
ISCs following injury (see Fig. S9 in the supplementary material),
and that after such injury yki mutant clones are decreased in size
and frequency relative to wild type (Fig. 4E). These data are
consistent with a cell-autonomous survival and proliferation
function for Yki in ISCs during damage. Furthermore, we have
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operate independently or interdependently, we activated Yki (by
overexpression or by Hpo depletion) and simultaneously activated
the JAK/STAT pathway (Fig. 5D). The proliferative effects of these
two pathway activities together resulted in greatly increased
division, suggesting a synergistic effect as division was greater than
that observed with either pathway alone. Moreover, the activation
of JAK/STAT pathway did not produce any obvious changes in Yki
localization (see Fig. S6C in the supplementary material). These
results support a model where the JAK/STAT and Hippo pathways
operate independently to activate processes in ISCs; however,
whereas JAK/STAT induces division alone, Yki induces division
only when JAK/STAT is also active at some level.
We investigated whether Hippo signaling might upregulate
JAK/STAT signaling. The activity of the JAK/STAT pathway was
increased when either yki was overexpressed or when hpo was
depleted in Esg(+) cells (Fig. 6A). Quantitative PCR revealed a
slight increase in Upd/Os and Upd2 transcripts, and a larger
increase in Upd3 transcript in midguts when hpo was depleted (Fig.
6B). Closer inspection of Esg(+) cells revealed that Upd/Os
cytokine production was increased in these precursors when yki
was overexpressed or when hpo was depleted (Fig. 6C). These
increases are reminiscent to what is observed following injury
(Jiang et al., 2009), suggesting that Upd(s) may be transcriptional
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Fig. 6. Yki activates the release of JAK/STAT
cytokines. (A)The activity of the JAK/STAT pathway,
using the stat-GFP reporter (stat-GFP is TubGal80TS/+; esg-Gal4/10xSTAT-GFP and where present
the overexpression constructs yki RNAi-1, yki or hpo
RNAi-1 are heterozygous on the third chromosome).
When either yki is overexpressed or hpo is depleted
by RNAi, an increase in STAT activity is observed. DSS
damage induces a similar increase even when yki is
depleted. (B)qPCR of tested transcripts following
hpo knockdown using the esg-Gal4 driver. Signal is
normalized to the control gene rp49 and levels are
shown normalized to esg>GFP controls; error bars
are s.e.m. (C)Upd/Os expression is elevated in Esg(+)
cells when either hpo is knoced down or when yki is
overexpressed (esg>GFP, upd-LacZ refers to
w1118/upd-LacZ; esg-Gal4, UAS-GFP, Tub-Gal80TS/+
and where present the overexpression constructs yki
RNAi-1, yki or hpo RNAi-1 are heterozygous on the
third chromosome). Normally signal is weak or nonexistent in wild type Esg(+) cells (esg>GFP, upd-LacZ),
but Esg(+) cells (arrows) become positive for updLacZ (red) during Yki-induced overgrowth (esg>yki,
upd-LacZ) or Hpo knockdown (esg>hpo RNAi-1,
upd-LacZ). Similar to the results above, Upd/Os signal
still shows an increase (arrows) during DSS damage
even when yki is depleted (esg>yki RNAi-1, updLacZ).

proliferative capacity of the ISC population during injury. These
models are not mutually exclusive. As mentioned above, we
observe the upregulation of Upd/Os, CycE and DIAP1, suggesting
that the activity of Yki may promote a complex transcriptional
response in ISCs to quickly heal tissues after damage.

Fig. 7. Hippo signaling restrains Yki-accelerated cell division in
response to injury. Schematic shows the transition of ISCs between
normal homeostasis, which occurs in the absence of injury, and acute
regeneration following injury. Upon damage, the Hippo pathway
ligand, Ds, no longer activates Hippo signaling in ISCs, allowing Yki to
activate downstream targets. One of these targets is the Upd/Os
cytokine, which stimulates proliferation of ISCs/Ebs through the
JAK/STAT pathway. When ee and EC progeny are regenerated, Hippo
signaling acts as a brake, cytokine production slows and the system
returns to the homeostatic state.
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analyzed the interaction between the Hippo pathway and the
JAK/STAT pathway, which has been previously implicated in ISC
regeneration (Jiang et al., 2009). Our analysis reveals that
JAK/STAT activity is required in ISCs for Yki-driven
overproliferation (Fig. 5), and suggests that Yki acts, in part, by
upregulating the Upd cytokines (Fig. 6). At least one of them,
Upd/Os, acts in an autocrine fashion (Fig. 6C) to activate STAT
(Fig. 6A).
Based on these findings, we propose that under normal
homeostasis Yki is inactive in ISCs, but becomes activated when
Hippo signal transduction is disrupted by cell contact cues resulting
from injury (Fig. 7). Yki activity then leads to the transcription of
known targets involved in proliferation (CycE), growth (bantam)
and the inhibition of cell death (DIAP1). The expression of Upd
cytokines is also transcribed following Yki activation (Fig. 6B) to
promote the division of ISCs.
Furthermore, we find that co-activation of Yki and STAT
increase division over either pathway alone (Fig. 5D). These results
are consistent with at least three hypothetical models of Hippo and
JAK/STAT integration in ISCs: (1) Yki directly activates Upd(s)
expression, further increasing the production of cytokines that
occurs following damage, in order to boost STAT activity; (2) Yki
may enhance STAT activity by increasing the expression of
intermediates, such as CycE which have been proposed to stabilize
STAT (Chen et al., 2003); (3) Yki activates both Upd/Os and
DIAP1 in ISCs, which promotes survival and enhances the

We note that others have reported that injury activates the JNK
pathway in ECs, which subsequently triggers the secretion of Upd
cytokines to act in a paracrine fashion on ISCs (Jiang et al., 2009).
Although we observed autocrine Upd/Os activity on ISCs, it is
likely that there are multiple sources of Upd(s) in this tissue: from
the surrounding muscle (Lin et al., 2010), the ECs (Jiang et al.,
2009) or other midgut epithelial cells (Beebe et al., 2010; Liu et al.,
2010). The respective roles and origin of the three Upd cytokines
(Upd/Os, Upd2 and Upd3) in this tissue will need to be further
clarified.
When Yki is activated in ISCs using the esg-Gal4 driver, we find
that all three cytokines are increased in the midgut (Fig. 6B),
reminiscent to what is observed during injury (Jiang et al., 2009).
Importantly, Yki activation in ISCs using the esg-Gal4 driver
increases Upd/Os production in ISCs themselves (Fig. 6C).
Recently, it has been reported that the kinase Wts regulates the
activity of Yki in ECs, and that ECs also provide a source of this
cytokine when Yki activation is carried out in ECs using the
myo1A-Gal4 driver (Staley and Irvine, 2010). Thus, in addition to
the role of the Hippo pathway in ISCs that we describe, inhibition
of Hippo signaling in damaged ECs also leads to production of
Upd cytokines. We note an increase in ISC division 18 hours after
Yki overexpression in ISCs using the esg-Gal4 driver, or in ECs
using the myo1A-Gal4 driver, and a synergistic effect when
overexpression was carried out in both simultaneously (see Fig.
S1C in the supplementary material). This suggests that Yki
activation in ISCs or ECs has autonomous and non-autonomous
effects on ISCs. Because we also observe an increase in DIAP1
expression in ECs during injury (see Fig. S8 in the supplementary
material), our findings are consistent with this report, and point to
a role for Hippo in regulating the regenerative response in both
ISCs and ECs in the midgut epithelium. The acute regeneration of
this tissue appears to be controlled by both an ISC autonomous and
non-autonomous response – both of which involve Hippo and
JAK/STAT signaling. It is interesting that, depending on the state
of the tissue, the Hippo pathway is used either as a means to
accelerate tissue repair by SCs or as a brake on SCs in order to
suppress tissue regeneration.
Hippo pathway members are strongly implicated in cancers,
as revealed by the findings that mutations in many pathway
members are enriched in human cancers (Zeng and Hong, 2008)
and that the human ortholog of Yki is an oncogene (Zender et
al., 2006). The issue of whether Hippo signaling occurs in SCs
or in differentiated cells is important in resolving the cell of
origin of carcinomas resulting from mutations in upstream Hippo
pathway components. In particular, the mammalian ortholog of
Merlin (Mer), NF2, has been shown to produce either
hepatocellular carcinoma (Zhang et al., 2010) or both
hepatocellular
carcinoma
and
cholangiocarcinoma
(Benhamouche et al., 2010). These contrasting reports bear
important conceptual implications in understanding Hippoinduced tumorigenesis, because hepatocellular carcinoma is
thought to originate from hepatocytes, while mixtures of both
hepatocellular carcinoma and cholangiocarcinoma are thought to
originate from the oval cell precursors of the liver. Thus, it is
crucial to identify the physiological role of the Hippo pathway
in both precursors versus their progeny, and the consequences of
perturbing this pathway in either (Breuhahn and Schirmacher,
2010). Finally, the connection between Yki and Stat
transcriptional activation in ISCs of the gut epithelium suggest
that STAT regulation in Hippo-driven cancers need to be
carefully evaluated.
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